Sean A. McCarthy, President and CEO at CytomX Therapeutics, Inc. (CTMX), sold 6,526 shares at $15.00 ($98K) on 2018-11-01, disclosed to the SEC on 2018-11-05.
Open-market sale of $98k CTMX by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $15.00 | 5,270 | $79K | 80.7% |
| 2 | $15.01 | 100 | $2K | 1.5% |
| 3 | $15.01 | 1,156 | $17K | 17.7% |
| Total | $15.00 avg | 6,526 | $98K | 100% |
| Filing → |
| CTMX | SELL | 2025-11-10 | $924K | — | Filing → |
| CTMX | SELL | 2025-06-17 | $299K | — | Filing → |
| CTMX | SELL | 2025-03-20 | $23K | — | Filing → |